Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/10/028482
CTRI/2020/10/028482
Active, not recruiting
Phase 2

Identifying and potentially mitigating biologic and treatment-related disparities in head and neck squamous cell carcinoma (HNSCC) in India

ational Institutes of Health USA0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: C32- Malignant neoplasm of larynxHealth Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C32- Malignant neoplasm of larynxHealth Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Sponsor
ational Institutes of Health USA
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institutes of Health USA

Eligibility Criteria

Inclusion Criteria

  • •1\) Squamous Cancer of oropharynx, larynx or hypopharynx
  • •2\) Stage III\-IV;
  • •3\) Planned for curative intent treatment with radiation \& concomitant platinum based chemotherapy;
  • •4\) Creatinine clearance (more than or equal to 50 mL/min prior to starting chemotherapy)
  • •5\) WHO performance status 0 or 1

Exclusion Criteria

  • •1\) Documented evidence of pre\-existing swallowing dysfunction (not related to HNC);
  • •2\) Previous radiotherapy to the head and neck region;
  • •3\) Major head and neck surgery (excluding biopsies/tonsillectomy);
  • •4\) Tracheostomy placement before the start of chemoradiation;
  • •5\) Previous or concurrent illness, which in the investigatorâ??s opinion would interfere with completion of therapy, trial assessments or follow\-up.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Biomarker based intervention strategies to combat adverse effects of shift workslaap, vermoeidheid, wellbevindenmetabolic healthsleep1000301810040991
NL-OMON53661Erasmus MC, Universitair Medisch Centrum Rotterdam75
Completed
Not Applicable
Detection of possible connections between biological factors or genetic polymorphisms and dentofacial and orthodontic phenotypesK00.2K07.0K07.1K07.3K07.8K00.6Major anomalies of jaw sizeAnomalies of jaw-cranial base relationshipAnomalies of tooth positionOther dentofacial anomaliesAbnormalities of size and form of teethDisturbances in tooth eruption
DRKS00020485Poliklinik für Kieferorthopädie,Universitätsklinikum Regensburg221
Completed
Not Applicable
Exploring biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer*s disease, schizophrenia, and major depression: replication and generalisability of the Psychiatric Ratings using Intermediate Stratified Markers (PRISM)1 studyAlzheimer's disease and Major Depressive Disorderpsychotic disorderdementia and depressionSchizophrenia10037176
NL-OMON53842Gregorio Marañón Hospital90
Recruiting
Not Applicable
Identification of risk factors and biomarkers for liver diseases, hepatocellular carcinoma, cholangiocarcinoma and gallbladder carcinoma. The ESCALON stduy.
NL-OMON48295Erasmus MC, Universitair Medisch Centrum Rotterdam1,950
Recruiting
Not Applicable
Identification of biomarkers in patients with diabetic macular edema
JPRN-jRCT1080223989SANTEN PHARMACEUTICAL CO., LTD.36